rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Guru Terug naar discussie overzicht

***** GTCB 2007 ******

2.783 Posts
Pagina: «« 1 ... 49 50 51 52 53 ... 140 »» | Laatste | Omlaag ↓
  10. [verwijderd] 3 april 2007 14:35

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    GTC Biotherapeutics Expands Business Development and Commercial Development Capabilities
    Tuesday April 3, 8:30 am ET


    FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today the expansion of its capabilities in business and commercial development. Ashley Lawton, Ph.D., GTC's new Vice President of Business Development, will focus primarily on additional strategic partnering for our proprietary programs, including monoclonal antibodies, as well as developing partners for follow-on biologics. Rick Finnegan, GTC's new Vice President of Commercial Development, will focus on market introduction strategies for our products, including through partners.
    ADVERTISEMENT



    "The approval in Europe validates our production technology for ATryn® and our portfolio of programs, enabling us to pursue our strategy for partnering and commercializing our products," stated Geoffrey F. Cox, Ph.D., GTC's Chairman of the Board and Chief Executive Officer. "I am pleased that executives of the caliber of Ashley Lawton and Rick Finnegan have joined us as we pursue our partnering and commercialization goals."

    Ashley Lawton has over 20 years of business development and management experience in the biotechnology and pharmaceutical industries in senior positions at Celltech Biologics, Inc., RepliGen Corporation, and Genzyme Corporation. His business development experience includes collaborative partnerships, license agreements, and manufacturing relationships with a wide range of large and small companies. He earned a Ph.D. in Biochemistry from Southampton University in the United Kingdom.

    Frederick "Rick" Finnegan has over 20 years of sales, marketing, and therapeutic product launch experience in senior positions at Critical Therapeutics, Genzyme Corporation, and Merck & Co. His commercial development experience includes the introduction of new products and the expansion of existing products in additional approved indications.


2.783 Posts
Pagina: «« 1 ... 49 50 51 52 53 ... 140 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.019
AB InBev 2 5.506
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.705
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.714
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.866
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.886
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.273
AMG 971 133.495
AMS 3 73
Amsterdam Commodities 305 6.691
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.009
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.781
Arcelor Mittal 2.033 320.724
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.306
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.192
ASML 1.766 107.584
ASR Nederland 21 4.498
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.675
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392